PerkinElmer to acquire Caliper Life Sciences
PerkinElmer has recently signed an agreement to acquire Caliper Life Sciences Inc., (Hopkinton, Massachusetts), a leader in imaging and detection solutions for life sciences, research, diagnostics and environmental markets .
PerkinElmer has recently signed an agreement to acquire Caliper Life Sciences Inc., (Hopkinton, Massachusetts), a leader in imaging and detection solutions for life sciences, research, diagnostics and environmental markets for a total net purchase price of approximately $600 million in cash.
Commenting on the acquisition, Robert F. Friel, chairman and chief executive officer, PerkinElmer, said, “The R&D, application expertise and intellectual property of the combined organization will provide our customers with enhanced knowledge and services and a strong pipeline of innovation. Additionally, the proven leadership and talent of the Caliper team will be a strong addition to our organization.”
As a result of the agreement, the company will be able to provide a number of additional services including further scope for molecular, cellular, animal and tissue imaging to enable translational medicine research; high-value sample preparation technologies for key scientific workflow areas such as next generation DNA sequencing and expansion into areas such as the detection of environmental contaminants and food pathogens.
Kevin Hrusovsky, chief executive officer, Caliper Life Sciences expressed his delight at becoming part of PerkinElmer and the opportunities that this will open up for making advances into improving human and environmental health.
For more information visit www.perkinelmer.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
